TLR2 and type 2 diabetes mellitus: In the peripheral nerves of T2DM mice, TLR2 antagonist CU-CPT22 repolarized M1 macrophages to M2 macrophages, decreased the release of cytokines, and ameliorated pain sensitivity in T2DM mice [97].